78 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Hba-a1tm1Ywk/Hbath-J involves: 129X1/SvJ * C57BL/6J	abnormal erythrocyte morphology	J:35018
	abnormal hemoglobin	J:35018
	anisocytosis	J:35018
	decreased fetal size	J:35018
	hemolytic anemia	J:35018
	leptocytosis	J:35018
	pallor	J:35018
	perinatal lethality, complete penetrance	J:35018
	poikilocytosis	J:35018
	polychromatophilia	J:35018
	reticulocytosis	J:35018
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBB*)Tow/Hbbtm2(HBG1,HBB*)Tow Not Specified	abnormal erythrocyte morphology	J:134980
	abnormal kidney corticomedullary boundary morphology	J:134980
	abnormal Kupffer cell morphology	J:134980
	abnormal liver morphology	J:134980
	abnormal spleen white pulp morphology	J:134980
	anemia	J:137709
	anisocytosis	J:134980
	decreased erythrocyte cell number	J:134980
	decreased hematocrit	J:134980
	decreased hemoglobin content	J:134980
	decreased urine osmolality	J:134980
	enlarged spleen	J:134980
	extramedullary hematopoiesis	J:134980
	focal hepatic necrosis	J:134980
	increased liver iron level	J:134980
	increased spleen red pulp amount	J:134980
	kidney vascular congestion	J:134980
	liver vascular congestion	J:134980
	poikilocytosis	J:134980
	polychromatophilia	J:134980
	reticulocytosis	J:134980
	spleen vascular congestion	J:134980
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBB*)Tow/Hbbtm2(HBG1,HBB*)Tow Slc12a4Rbc10/Slc12a4+ involves: 129 * BALB/c * C57BL/6J	abnormal erythrocyte physiology	J:227339
	abnormal liver morphology	J:227339
	abnormal lung morphology	J:227339
	abnormal pulmonary circulation	J:227339
	abnormal renal tubule morphology	J:227339
	enlarged spleen	J:227339
	hepatic necrosis	J:227339
	increased mesangial cell number	J:227339
	liver inflammation	J:227339
	microcytic anemia	J:227339
	premature death	J:227339
	reticulocytosis	J:227339
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBB*)Tow/Hbbtm2(HBG1,HBB*)Tow Slc12a4Rbc10/Slc12a4Rbc10 involves: 129 * BALB/c * C57BL/6J	premature death	J:227339
	preweaning lethality, incomplete penetrance	J:227339
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBB*)Tow/Hbbtm3(HBG1,HBB)Tow Not Specified	anemia	J:137709
	normal hematopoietic system phenotype	J:134980
	normal liver/biliary system phenotype	J:134980
	normal renal/urinary system phenotype	J:134980
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBB*)Tow/Hbbtm3(HBG1,HBB)Tow Slc12a4Rbc10/Slc12a4Rbc10 involves: 129 * BALB/c * C57BL/6J	microcytic anemia	J:227339
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBD,HBB*)Ryan/Hbbtm2(HBG1,HBD,HBB*)Ryan Not Specified	abnormal proerythroblast morphology	J:148521
	anemia	J:148521
	anisopoikilocytosis	J:148521
	decreased hemoglobin content	J:148521
	decreased mean corpuscular volume	J:148521
	extramedullary hematopoiesis	J:148521
	hemolytic anemia	J:148521
	increased circulating bilirubin level	J:148521
	intermingled spleen red and white pulp	J:148521
	low mean erythrocyte cell number	J:148521
	polychromatophilia	J:148521
	premature death	J:148521
	reticulocytosis	J:148521
	spherocytosis	J:148521
	spleen hyperplasia	J:148521
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBD,HBB*)Ryan/Hbbtm3(HBG1,HBB)Tow Not Specified	abnormal definitive hematopoiesis	J:148521
	decreased hemoglobin content	J:148521
	decreased mean corpuscular volume	J:148521
	high mean erythrocyte cell number	J:148521
	reticulocytosis	J:148521
	spleen hyperplasia	J:148521
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm3(HBG1,HBB)Tow/Hbbtm3(HBG1,HBB)Tow Not Specified	anemia	J:137709
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm4(HBB*)Tow/Hbbtm4(HBB*)Tow Not Specified	abnormal erythrocyte physiology	J:137709
	anemia	J:137709
	normal cardiovascular system phenotype	J:137709
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm5(HBG1,HBB*)Tow/Hbbtm5(HBG1,HBB*)Tow Not Specified	abnormal erythrocyte physiology	J:137709
	anemia	J:137709
	normal cardiovascular system phenotype	J:137709
Hbatm1Paz/Hba+ Hbbtm1Tow/Hbbtm1Tow involves: 129S2/SvPas * 129S7/SvEvBrd	abnormal erythroid progenitor cell morphology	J:204029
	decreased erythroid progenitor cell number	J:204029
Hbatm1Paz/Hbatm1Paz Hbbtm1Tow/Hbb+ involves: 129S2/SvPas * 129S7/SvEvBrd	normal hematopoietic system phenotype	J:204029
Hbatm1Paz/Hbatm1Paz Hbbtm1Tow/Hbbtm1Tow involves: 129S2/SvPas * 129S7/SvEvBrd	abnormal embryonic erythrocyte morphology	J:204029
	abnormal embryonic erythropoiesis	J:204029
	abnormal erythroid progenitor cell morphology	J:204029
	decreased embryo size	J:204029
	decreased erythroid progenitor cell number	J:204029
	embryonic lethality during organogenesis, complete penetrance	J:204029
	liver hypoplasia	J:204029
	microcytic anemia	J:204029
	microcytosis	J:204029
	pallor	J:204029
	small liver	J:204029
Hbatm1Paz/Hbatm1Paz Hbbtm1Tow/Hbbtm1Tow Tg(HBA-HBBs)41Paz/0 involves: 129 * Black Swiss * C57BL/6 * DBA/2 * FVB/N	abnormal penile erection	J:135978
	priapism	J:135978
Hbatm1Paz/Hbatm1Paz Hbbtm1Tow/Hbbtm1Tow Tg(HBA-HBBs)41Paz/? involves: 129S2/SvPas * 129S7/SvEvBrd * Black Swiss * C57BL/6 * DBA/2* FVB/N	abnormal erythrocyte morphology	J:44161
	abnormal hemoglobin	J:44161
	abnormal kidney vasculature morphology	J:44161
	abnormal liver vasculature morphology	J:44161
	abnormal lung vasculature morphology	J:44161
	anemia	J:44161
	anisopoikilocytosis	J:44161
	decreased erythrocyte osmotic fragility	J:44161
	decreased hematocrit	J:44161
	decreased mean corpuscular hemoglobin	J:44161
	decreased mean corpuscular hemoglobin concentration	J:44161
	decreased mean corpuscular volume	J:44161
	hypoxia	J:44161
	increased heart weight	J:44161
	increased kidney iron level	J:44161
	increased kidney weight	J:44161
	increased liver iron level	J:44161
	increased spleen weight	J:44161
	kidney atrophy	J:44161
	kidney cyst	J:44161
	neonatal lethality, incomplete penetrance	J:44161
	renal fibrosis	J:44161
	reticulocytosis	J:44161
	spleen vascular congestion	J:44161